Get the Stockscreener App
3.5402
1.15%
0.0402
Avalon Globocare Corp stock is traded at $3.5402, with a volume of 1,735.
It is up +1.15% in the last 24 hours and down -6.34% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$3.50
Open:
$3.73
24h Volume:
1,735
Relative Volume:
0.00
Market Cap:
$3.83M
Revenue:
$1.31M
Net Income/Loss:
$-14.73M
P/E Ratio:
-0.1772
EPS:
-19.98
Net Cash Flow:
$-4.69M
1W Performance:
+7.60%
1M Performance:
-6.34%
6M Performance:
-13.36%
1Y Performance:
-38.05%
1-Day Range:
$3.51
$3.73
1-Week Range:
$3.23
$3.73
52-Week Range:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Compare ALBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALBT
Avalon Globocare Corp
|
3.51 | 3.83M | 1.31M | -14.73M | -4.69M | -19.98 |
|
CBRE
Cbre Group Inc
|
143.29 | 44.24B | 34.31B | 958.00M | 913.00M | 3.11 |
|
XHG
Xchange Tec Inc Adr
|
0.70 | 39.43B | 40.28M | -31.64M | -1.36M | 228.31 |
|
CSGP
Costar Group Inc
|
77.44 | 32.05B | 2.67B | 175.40M | -61.90M | 0.44 |
|
BEKE
Ke Holdings Inc Adr
|
17.96 | 21.38B | 10.78B | 579.98M | 881.47M | 0.493 |
|
JLL
Jones Lang Lasalle Inc
|
280.42 | 13.41B | 22.50B | 478.00M | 411.90M | 9.89 |
Avalon Globocare Corp Stock (ALBT) Latest News
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Head to Head Analysis: Sangamo Therapeutics (NASDAQ:SGMO) versus Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare announces preferred stock exchange and amendment By Investing.com - Investing.com Australia
Avalon GloboCare announces preferred stock exchange and amendment - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific and Clinical Advisory Board - Marketscreener.com
Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest - Defense World
Avalon GloboCare Enters into Securities Purchase Agreement with InvestorOn December 19, 2024, Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it had entered into a securities purchase agreement with an accredited investor, York Sun Investme - Defense World
Avalon GloboCare announces $7M preferred stock sale By Investing.com - Investing.com Nigeria
Avalon GloboCare announces $7M preferred stock sale - Investing.com India
Avalon GloboCare (NASDAQ:ALBT) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Analysis - Defense World
3 Penny Stocks to Watch Now, 12/10/24 - TipRanks
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Avalon GloboCare Regains Nasdaq Compliance - Investing.com
Avalon GloboCare Achieves Nasdaq Compliance with Strong Governance - TipRanks
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements - GlobeNewswire
Avalon GloboCare Regains Nasdaq Compliance, Reaffirms Growth Strategy | ALBT Stock News - StockTitan
Avalon launches ‘BrAce for Impact’ affiliate marketing program - TipRanks
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewswire
Avalon GloboCare Launches AI-Powered KetoAir™ Affiliate Program for Ketosis Monitoring | ALBT Stock News - StockTitan
Critical Review: Innate Pharma (NASDAQ:IPHA) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Yahoo Finance
Avalon GloboCare Corp. (ALBT) Quarterly 10-Q Report - Quartz
U.S. Stock market: Zoomcar Holdings (+192.21%), Avalon GloboCare (+56.73%), and Vimeo (+40.85%) experience significant gains during mid day trading - Business Upturn
U.S. Stock market: Zoomcar Holdings up 87.10%, Avalon GloboCare jumps 57.14%, Vimeo rises 44.07% among top gainers - Business Upturn
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges - Investing.com Canada
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges By Investing.com - Investing.com South Africa
Avalon GloboCare faces Nasdaq delisting after rule breach - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to Scientific Advisory Board Support for KetoAir Sales - Defense World
Avalon GloboCare faces Nasdaq delisting after rule breach By Investing.com - Investing.com South Africa
Avalon appoints Cavto to Scientific Advisory Board - TipRanks
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - GlobeNewswire
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares By Investing.com - Investing.com South Africa
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares - Investing.com
Avalon Globocare stock hits 52-week high at $3.45 By Investing.com - Investing.com South Africa
Avalon Globocare stock hits 52-week high at $3.45 - Investing.com
Avalon GloboCare Stock Set to Reverse Split on Monday, October 28th (NASDAQ:ALBT) - Defense World
Avalon GloboCare Collaborates for Cannabis Breathalyzer Development - TipRanks
Avalon, enters MOU with Qi Diagnostics - TipRanks
Avalon GloboCare and Qi Diagnostics Enter into Memorandum - GlobeNewswire
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):